519 results
Innovation fireworks
20 May 2022 – From EuroPCR 2022
Find out more about novel innovative techniques and devices including: Leaflex, a possible alternative to balloon valvuloplasty, Valvosoft, a non-invasive ultrasound therapy or even home blood potassium monitoring!
Transcatheter tricuspid valve repair: CLASP TR study one-year results
19 May 2022 – From EuroPCR 2022
Alessandro Sticchi asks Rebecca Hahn about the one-year results of the CLASP TR study and the impact it will have on the management of tricuspid regurgitation.
Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip bRIGHT study
20 May 2022 – From EuroPCR 2022
Philip Lurz speaks with Alessandro Sticchi about the 30-day results from the TriClip bRIGHT study on 300 subjects with symptomatic tricuspid regurgitation. He also shares his perspective on the future of edge to edge treatment in the tricuspid field.
TriClip therapy: here now, here to stay
19 May 2022 – From EuroPCR 2022
Discover how tricuspid clip dedicated therapy allows treating a broad range of anatomies through real-life cases. Also, learn about its real-world outcomes and the performance in different tricuspid regurgitation patient profiles.
A patient-focused transcatheter portfolio of options to treat tricuspid regurgitation
19 May 2022 – From EuroPCR 2022
In this session from EuroPCR 2022, the speakers introduce different options available for treating tricuspid regurgitation. They discuss the anatomical considerations that define suitable candidates and review different transcatheter options and their key differentiators.
PCR Innovators Day - Innovations for valve treatment: new devices, new tools, new procedures
19 May 2022 – From EuroPCR 2022
Valvular heart disease is probably one of the most innovative areas in cardiovascular medicine at large: tremendous progress has been made both in terms of quality of life and mortality. Technology continues to evolve, as there are still many gaps to be filled, and it is...
EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in mitral and tricuspid! MitraClip in atrial functional mitral regurgitation, two-year outcomes of MitraClip as a bridge to heart transplantation, TriCLASP post-market study, CLASP TR study one-year results, Cardioband TR early feasibility study, and initial 30-day results from...
Treating tricuspid regurgitation percutaneously: tools and impacts
19 May 2022 – From EuroPCR 2022
Discover the tools and impacts of treating tricuspid regurgitation percutaneously by watching the cases of valve replacement, valve-in-ring implantation, transcatheter edge-to-edge repair and many more.
What did 2022 tell us so far in interventions? Essential publications from the EuroIntervention Journal and the European Heart Journal
19 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session lists the best EIJ and EHJ publications in terms of coronary interventions, intravascular imaging and physiology, interventions for mitral and tricuspid valve disease, and interventions for aortic valve disease.
Bright future ahead for tricuspid regurgitation management
19 May 2022 – From EuroPCR 2022
In this conversation between Philipp Lurz and Felix Kreidel, recorded for EuroPCR 2022, learn more about the bRIGHT study and the latest outcomes released, and further understand TriClip therapy real-world outcomes applicability in daily practice.
View more videos and course resources here!
